Skip to main content

Cardiology Update London 2023

London, UK
Type of event
on site


Dear Colleagues

It is a real pleasure to welcome you the 7th Christmas Postgraduate Course of the Royal Brompton and Harefield NHS Foundation Trust & Imperial College, the Cardiology Update London.

Programme Overview

Programme Overview

Monday , December 11th (UK Time) Tuesday, December 12th (UK Time)
8:30 -09:45 Welcome Address
Opening Lectures
  • Frontiers in cardiovascular science
8:30-10:30 Session 4
Arrhythmias and SCD
  • Atrial fibrillation
  • Cardiogenic shock and effect of assist devices (Impella)
9:45-10:15 Coffee 10:30-11:00 Coffee
10:15-12:30 Session 1
Risk Factors and Prevention Guidelines
  • Dyslipidaemias
  • siRNA therapeutics
  • Hypertension
  • Genetics for personalised risk assessment
  • Influenza and CV outcomes:
11:00-12:30 Session 5
Structural Heart Disease
  • Aortic, mitral and tricuspid
  • valve disease
  • Multiple heart valve disease
12:30-13:15 Industry Sponsored Session 12:30-13:15 Industry Sponsored Session
13:15-14:00 Lunch Break 13:15-14:00 Lunch Break
14:00-16:00 Session 2
Acute and Chronic Coronary Syndromes
  • ESC 2023 ACS Guidelines
  • Management of ACS
  • Medical therapy or intervention
  • Antithrombotic therapy




The Paul Hamilton Wood Lecture


    Session 6
    Heart Failure: Pharmacotherapy

    • Update of ESC Guidelines
    • Anaemia und iron substitution
    • New and emerging therapies
    16:00-16:30 Coffee 15:45-16:15 Coffee
    16:30-18:30 Session 3
    The ESC 2023 Guidelines
    • Diabetes
    • Cardiomyopathies
    • Endocarditis
    16:15-17:15 Session 7
    Cardiorenal Syndrome Cardiomyopathies
    • Genetic causes of heart failure
    18:30-20:00 Networking Reception 17:15 Adjourn


    Monday, December 11th, 2023 (UK time)

    Venue: The Royal Society of Medicine

    08:30-09:00 | Welcome Address  
    08:30 Welcome by the ESC President:
    The future of Cardiology in Europe
    Thomas F. Lüscher, London


    08:45 - 09:45 | Opening Lectures: Frontiers in Cardiovascular Science
    Chair: Thomas F. Lüscher, London and Filippo Crea, Rome
    08:45 Opening Lectures 1:
    Lipoprotein (a) a risk factor for CAD and aortic stenosis?

    Hugh Watkins, Oxford

    09:15 Opening Lecture 2:
    Digital health in current clinical practice

    Lale Tokgözoğlu, Ankara

    09:45- 10:15 COFFEE BREAK  


    10:15 - 12:30 | Session 1: Risk Factors and Prevention
    Chairs: Mahmoud Barbier, Harefield and NN
    10:15 Is targeting inflammation ready for prime time? Peter Libby, Boston

    Development of nucleic-acid based therapies to
    lower atherogenic lipoproteins

    Ulf Landmesser, Berlin
    10:55 Novel antilipidaemic drugs: : CLEAR and clinical practice Kausik Ray, London
    11:15 The 2023 ESC Guidelines on Cardiovascular Disease and Diabetes Nikolaus Marx, Aachen
    11:35 Obesity: New options for an epidemiological challenge Naveed Sattar, Glasgow
    11:55 Panel Discussion All


    12:30 - 13:15 | Industry sponsored symposium
    13:15-14:00 Lunch Buffet  


    14:00 - 16:15 | Session 2: Acute and Chronic Coronary Syndromes
    Chairs: Richard Grocott-Mason, London and Peter Libby, Boston
    14:00 Intracoronary imaging and clinical outcomes    Lorenz Räber, Bern
    14:20 ESC 2023 Guidelines on Acute Coronary Syndromes Borja Ibáñez, Madrid
    14:40 Challenges in PCI: high-risk and complex lesions (CHIP) Jonathan Hill, London
    15:00 Patient case TBD

    Mohammed Majid Akhtar,

    15:20 From plaque rupture to erosion: A step towards precision medicine? Filippo Crea, Rome
    15:40 PCI for ischemic cardiomyopathy: The Revived Trial Divaka Perera, London
    16:00 Panel Discussion  
    16:15- 16:45 COFFEE BREAK  


    16:45 - 17:15 | Industry sponsored symposium


    17:15 - 18:45 | Session 3: Practical Implications of the new ESC 2023 Guidelines
    Chairs: NN and NN
    17:15 Cardiomyopathies Juan Pablo Kaski, London
    17:30 Q&A  
    17:40 Endocarditis Victoria Delgado, Badalona
    17:55 Q&A  
    18:15    Cross-functional Networking Reception


    Tuesday, December 12th, 2023 (UK Time)

    Venue: The Royal Society of Medicine

    08:30 - 10:30 | Session 4: Arrhythmias, Sudden Cardiac Death
    Chairs: NN and NN
    08:30 Pulse field ablation of atrial fibrillation: A revolution?    Gerhard Hindricks, Berlin
    08:50 Upstream therapy for the prevention of AF: Is it realistic? Bernard Gersh, Rochester
    09:10 My patient with AF and ischemic heart disease Shouvik Haldar, London
    09:30 Cardiogenic shock and effect of assist devices Susanna Price, London
    09:50 Personalized indication for ICD? Genetics, fibrosis and LVEF Lars Køber, Copenhagen
    10:10 Panel discussion All
    10:30-11:00 COFFEE BREAK  


    11:00- 12:45 | Session 5: Valvular Heart Disease
    Chairs: Miles Dalby, London and NN
    11:00 Multimodality imaging in transcatheter aortic valve replacement Jeroen J. Bax, Leiden
    11:20 TAVI versus SAVR: moving indications? Stephan Windecker, Berne
    11:40 Secondary mitral regurgitation: Medication, TEER or surgery? Francesco Maisano, Milano
    12:00 TEER for tricuspid regurgitation: ILLUMINATE and beyond Georg Nickenig, Bonn
    12:20 Panel discussion  


    12:30 - 13:15 | Industry Sponsored Symposium
    13:15-14:00    Lunch Buffet


    14:00 - 14:30 | The Paul Hamilton Wood Lecture
    Chairs: Bernard J. Gersh, Rochester MN and Thomas F. Lüscher, London


    14:30 - 15:45 | Session 6: Heart Failure: Established and Novel Drugs / Advanced Stage
    Chairs: Paul Kalra, Portsmouth and Giuseppe Rosano, London
    14:30 Focused update on the 2021 ESC HF Guidelines Theresa McDonagh, London
    14:50 HFpEF: From hemodynamics to management Barry Borlaug, Rochester
    15:10 Iron deficiency in heart failure    Paul Kalra, Portsmouth
    15:30 Panel discussion  
    15:45 - 16:00 COFFEE BREAK  


    16:00 - 17:15 | Session 7: Heart, Kidney and Amyloidosis
    Chairs: NN and NN
    16:00 Is LVEF still important for HF management? John McMurray. Glasgow
    16:20 The cardiorenal axis: new treatment targets David C. Wheeler, London
    16:40 Cardio-oncology: What is the evidence today? Sohaib Nazir, London
    17:00 Panel discussion  
    17:15 Wrap-up and Adjourn Thomas F. Lüscher, London


    Updated: 12.05.2023



    Registration fees  
    Regular fee GBP 300
    Early registration fee (until November 10, 2023) GBP 250
    ESC / Association Members  
    Regular fee GBP 250
    Early registration fee (until November 10, 2023) GBP 200
    Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)*  
    Regular fee GBP 150
    Early registration fee (until November 10, 2023) GBP 100
    Day Ticket GBP 150
    Group Registration (For group registrations a minimum of 10 participants is required)**  
    Regular fee GBP 260
    Early registration fee (until November 10, 2023) GBP 210

    *For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Nadine-Estelle Abea at

    **Please contact Ms. Nadine-Estelle Kaltheuner ( at the Zurich Heart House to obtain further information.

    Registration will be confirmed upon receipt of payment.
    Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

    Modification & Cancellation

    All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to the Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancel-lation up to 1st of November 2023, deposits will be refunded less 35 % for administrative costs. After this date, no refund will be possible.


    Zurich Heart House, Foundation for Cardiovascular Research
    Dr. Ruth Amstein
    Nadine-Estelle Abea
    Hottingerstrasse 14, CH-8032 Zurich, Switzerland
    Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90

    Organized by

    In collaboration with